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http://dx.doi.org/10.1016/j.fjs.2012.Summary Background: Chronic subdural hematoma (CSDH) in patients 65 years old is not
uncommon, but its exact situation is not well-clarified.
Purposes: In this study, we compare the clinical variables between two age groups (65 years
and >65 years), and focus on the characteristics of younger adults.
Methods: In this 2-year retrospective study, 98 patients with CSDH were enrolled and subdi-
vided into younger (65 years) and older (>65 years) groups. Information about presenting
symptoms and neuroimages was recorded. We also investigated recurrence, morbidity,
mortality, and neurological outcome after burr hole craniotomy.
Results: The patients 65 years accounted for 29% of the CSDH cases. Younger adults had
a lower incidence of hemiparesis than older patients (pZ 0.03). Analysis of the computerized
tomography (CT) scans on admission revealed differences in layering of the hematoma
(p Z 0.009) and multiplicity of hematoma cavities (p Z 0.001). The recurrence rate was
18% for the younger group and 13% for the older group (p Z 0.53). The occurrence of postop-
erative morbidity and mortality was similar in the two age groups (p > 0.99 and p Z 0.56,
respectively). An unfavorable Glasgow Outcome Scale was not observed in any of the younger
patients, but was seen in six of the older patients; however, there was no statistically signif-
icant difference between the age groups (p Z 0.18).
Conclusion: The clinical presentations and CT features of patients 65 years of age varied
from those of older patients. Clinicians should note this variability to facilitate proper manage-
ment.
Copyright ª 2012, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.t of Neurosurgery, Kaohsiung Chang Gung Memorial Hospital, 123, Ta Pei Road, Niao Sung District,
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Chronic subdural hematoma in patients under age 65 years 111. Introduction hematoma measured at the maximal diameter of theChronic subdural hematoma (CSDH) is one of the most
common types of neurological diseases, and is often
preceded byminor head trauma, in which a tear in a bridging
vein results in the collection of subdural blood. Its incidence
is about 5/100,000/year in the general population, but it has
a higher prevalence in the elderly.1,2 In a report on the long-
term outcome of CSDH in extremely aged patients, the
authors observed a persistent excess of mortality up to 1
year after diagnosis of CSDH.3 This belies the notion that the
patient’s age influences the clinical picture of CSDH.
Although most clinicians focus on the elderly in the majority
of studies, CSDH in young adults is not rare in neurosurgical
practice. Whether the young population differs from the
elderly in clinical manifestations or significance, has not
been well clarified so far. Therefore, in the present study,
we retrospectively analyzed symptomatic presentation,
neurological grading, imaging findings, and surgical
outcomes in patients with CSDH, and attempt to identify the
differences in clinical details between patients65 years of
age and older patients.
2. Patients and methods
Over a period of 2 years, 151 patients who suffered from
CSDH were admitted to the Department of Neurosurgery at
Kaohsiung Chang Gung Memorial Hospital, which is a major
medical center in southern Taiwan.
The criteria of CSDH for inclusion were as follows: (1)
a computerized tomography (CT) scan showing isodense to
hypodense hematomas with respect to the adjacent brain;
and (2) a fluid hematoma (usually >21 days after injury)
identified at the time of surgery.4 Patients were excluded
if: (1) they had other concomitant types of traumatic brain
injury, including brain contusion, epidural hematoma,
acute subdural hematoma, intracerebral hematoma,
intraventricular hemorrhage, or subarachnoid hemorrhage;
(2) CSDH had resulted from complications of prior neuro-
surgical procedures, such as craniotomy, external ventric-
ular drainage, or ventriculoperitoneal shunt; (3) the
patients had been receiving conservative treatment for
CSDH without surgical management; and (4) if the images of
the brain acquired at admission by magnetic resonance
imaging or a CT scan could not be assessed because of
missing data or poor image quality. Thus, only 98 of the
patients were enrolled for analysis. Then, we subdivided
the study population into two groups according to age (65
years and >65 years). The clinical manifestations of the
two groups of patients with CSDH are compared. The study
protocol on CSDH was approved by the Institutional Review
Committee on Human Research at the Chang Gung Memo-
rial Hospital.
The patients underwent brain CT after arrival at our
hospital. Follow-up brain CT scans were taken if clinical
deterioration was noted, including acute onset of focal
neurological deficits, or progressive disturbance of
consciousness, and also for post neurosurgical procedures.
Brain CT scans were interpreted with respect to the
following findings: (1) the site of the hematoma (unilateral
or bilateral cerebral convexity); (2) the thickness of theunilateral hematoma, or the sum of the maximal diameters
of the bilateral hematomas; (3) the midline shift defined as
deviation of the septum pellucidum, by >1 cm from the
central position; (4) the mass effect determined by
effacement of the sulci, Sylvian fissure obscuration, or
compression of lateral ventricles; (5) layering of the
hematoma, defined as containing two components of
different densities with a clear boundary between them;
and (6) multiplicity of hematoma cavities, defined as
a hematoma with inhomogeneous content and a high-
density septum running between the inner and outer
membranes.5 Brain atrophy was classified into three stages:
(1) mild or no atrophy; (2) definite atrophy showing such
evidence as dilated sulci; and (3) severe atrophy showing
such signs as widely dilated sulci and subdural space.6 We
also measured the Hounsfield units (HU) of the hematomas
at the sites of highest density based on CT scans taken at
the time of admission.
The initial surgical procedure in all 98 patients was
performed using one or two burr holes on each affected
side, for irrigation of the hematoma. Subdural liquefied
blood was washed out using physiological saline solution.
All patients underwent closed-system drainage, performed
with the aid of a silicone tube inserted in the subdural
space and tunneled under the scalp to the exit point of the
incision line. The drains were removed once drainage had
stopped or significantly decreased, and the patients had
shown an improvement in initial symptoms. Craniotomy was
reserved for patients with recurrent subdural hematoma
and in whom the underlying membranes prevented
adequate reexpansion of the brain. The clinical and radio-
logical criteria were integrated to evaluate recurrence and
judge the need for reoperation. Reappearance of symptoms
such as hemiparesis, headache, or changes in consciousness
was deemed to indicate the reaccumulation of subdural
hematoma. The radiological criteria consisted of an
increase in the thickness of hematoma and a change in the
density of hematoma on the treated side, in follow-up CT
scans recorded within 3 months postoperatively.5
Characteristics of the 98 patients were documented,
including age, gender, history of head injury, mechanisms
of head injury, underlying systemic diseases, and anti-
platelet or anticoagulant therapy. The presenting symp-
toms were headache, nausea or vomiting, hemiparesis,
mental change, or seizures that occurred in close temporal
relationship with CSDH. The Glasgow Coma Scale (GCS) and
Markwalder Subdural Hematoma Grade7 were determined
by neurosurgeons when the patient arrived at the emer-
gency room. Postoperative morbidity, consisting of acute
subdural hemorrhage, infection of the central nervous
system, new-onset seizure, pneumonia, or urinary tract
infection, was identified, and the length of previous
hospital stay was recorded. The neurological outcome was
assessed at the end of the follow-up period using the
Glasgow Outcome Scale (GOS). Unfavorable and favorable
outcomes were defined by a GOS score of 1e3 and 4e5,
respectively. The follow-up was terminated either at the
end of the study (June 2007) or earlier, owing to death of
the patient. After discharge, within the period mentioned
above, the patients were followed-up at the outpatient
department to determine the neurological outcome.
12 W.-L. Lo et al.All statistical analyses were conducted using SPSS
version 12.0 (SPSS Inc., Chicago, IL, USA). The quality of the
means for continuous variables was assessed using the
Student t test or Mann-Whitney U-test. Categorical vari-
ables were analyzed using the Chi-square test or Fisher’s
exact test. A p value of 0.05 was considered statistically
significant.3. Results
Among the 98 patients with CSDH, 81 were males and 17
were females. Their mean age at diagnosis was
69.30  12.76 years (range Z 29e93 years). Twenty-eight
patients were 65 years old and 70 patients were >65 years
old. The mean duration of follow-up was 10.66  10.14
months. We compared the clinical manifestations of the
two groups of patients aged 65 years and >65 years,
below.
3.1. Clinical characteristics
The male to female ratio was similar in the two groups,
being 24/4 in patients 65 years old and 57/13 in patients
>65 years old (pZ 0.77), but the prevalence of underlying
medical conditions, including hypertension, diabetes mel-
litus, stroke, and antiplatelet therapy, was less common in
the younger group. In the 73 patients with a history of head
injury, the younger patients often had traffic accidents (14/
23), and the injury in older patients usually resulted from
accidental falls (27/50) (p Z 0.03). The presenting symp-
toms revealed a significant intergroup difference in the
occurrence of hemiparesis (p Z 0.03), but no significant
differences were found in the occurrence of headacheTable 1 Comparison of clinical characteristics between two ag
65 y
n Z 28
Gender (male/female) 24/4
History of head injury 23
Underlying medical condition
Diabetes mellitus 3
End-stage renal disease 1
Hypertension 5
Stroke 0
Dementia 0
Parkinson’s disease 0
Alcoholism 7
Antiplatelet therapy 0
Anticoagulant therapy 0
Symptom/sign
Headache 14
Nausea or vomiting 6
Hemiparesis 10
Mental change 14
Seizure 1
Mean GCS at admission 13.61  2.54
Mean Markwalder
SDH Grade at admission
1.86  0.71(p Z 0.30), seizures (p > 0.99), nausea or vomiting
(pZ 0.66), or mental change (pZ 0.80). The mean GCS at
admission was 13.61  2.54 and 14.10  1.85 in the younger
and older CSDH groups, respectively, (pZ 0.72). The mean
Markwalder subdural hematoma grade at admission was
1.86  0.71 in the younger patients and 1.81  0.60 in the
older patients (p Z 0.51). The baseline clinical character-
istics of the two age groups are compared in Table 1.
3.2. Imaging findings
Based on brain CT scans on admission, the incidence of
unilateral or bilateral CSDH was found to be similar
between the two age groups (p Z 0.34). The presence of
a midline shift was identified in 14/28 younger CSDH
patients and 25/70 older patients (p Z 0.19). The mean
thickness of the hematomas was 22.74  11.46 mm and
23.12  10.37 mm in the younger and older groups,
respectively (p Z 0.87). The mean HU of the hematoma
was 33.04  12.11 in the younger CSDH patients and
36.10  10.67 in the older patients (p Z 0.22). The other
features of the CT scans obtained in the two groups showed
significant differences in layering of the hematoma
(p Z 0.009) and multiplicity of hematoma cavities
(p Z 0.001), but not in the presence of a mass effect
(p > 0.99). There were fewer patients with severe brain
atrophy in the younger group (p Z 0.02). A comparison of
neuroimaging findings between younger and older patients
is given in Table 2.
3.3. Outcomes and recurrence
Postoperative morbidity occurred in four young patients
and included one occurrence of acute subdurale groups of patients with CSDH.
>65 y p
n Z 70
57/13 0.77
50 0.27
26 0.01
1 0.49
46 <0.001
17 0.002
7 0.19
2 >0.99
7 0.11
13 0.02
2 >0.99
27 0.30
18 0.66
42 0.03
33 0.80
3 >0.99
14.10  1.85 0.72
1.81  0.60 0.51
Table 2 Comparison of CT features between two age groups of patients with CSDH.
65 y >65 y p
n Z 28 n Z 70
Bilateral/unilateral hematoma 9/19 16/54 0.34
Presence of mass effect 27 67 >0.99
Presence of layering 1 19 0.009
Multiplicity of hematoma cavities 3 32 0.001
Midline shift 14 25 0.19
Severe brain atrophy 2 20 0.02
Density of hematoma (HU) 33.04  12.11 36.10  10.67 0.22
Thickness of hematoma 22.74  11.46 23.12  10.37 0.87
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monia, and none of urinary tract infection or infection of
the central nervous system. Nine patients in the older group
had morbidities, including new onset seizures in four
patients, pneumonia in three, and urinary tract infection in
four, but no patient had acute subdural hemorrhage or
infection of the central nervous system. Of the 28 younger
patients, none died in the follow-up period. Two of the 70
old patients died from pneumonia complicated by respira-
tory failure, and one died due to non-Hodgkin lymphoma
during the follow-up period. There was no statistically
significant intergroup difference in mortality after the
treatment of CSDH (p Z 0.56). Neurological outcomes in
these 98 patients were determined by GOS and were as
follows: 74 patients had a normal life, 18 had moderate
disabilities, one had severe disabilities, two were in
a persistent vegetative state, and three died. An unfavor-
able GOS score at the end of the follow-up was observed in
six older patients and in none of the younger patients
(pZ 0.18). The mean hospital stay was 14.32  12.96 days
in the younger group, and 12.71  12.92 days in the older
group (p Z 0.58). Recurrence of CSDH within 3 months
after the burr hole craniotomy was found in 5/28 younger
patients (18%) and 9/70 older CSDH patients (13%). There
was no statistically significant intergroup difference
(pZ 0.53). Clinical results in relation to the ages are listed
in Table 3.4. Discussion
CSDH is nowadays often considered to be a benign entity.
However, based on a series of 209 aged patients (averageTable 3 Comparison of the clinical results between two age gr
65 y
n Z 28
Mean hospital stay (d) 14.32  12.9
Postoperative morbidity 4
Postoperative mortality 0
Recurrence of CSDH 5
Unfavorable/favorable outcome 0/28age Z 80.6 years; range Z 65e96 years) with CSDH,3
Miranda et al found that the overall mortality rates at 6
months and 1 year were 26.3% and 32%, respectively, and
concluded that CSDH in the elderly may not be a benign
disease. Hence, the impact of age on the clinical manifes-
tation and prognosis of CSDH should receive attention.
Although the neurosurgical literature primarily focuses on
the elderly, we found that 28/ 98 (29%) of the CSDH
patients were 65 years of age. As expected, the younger
patients have fewer medical illnesses, such as hyperten-
sion, diabetes mellitus, stroke, or the requirement for
antiplatelet therapy. By contrast, among patients with
a prior head injury, the younger adults are often involved in
violent motor vehicle accidents rather than trivial fall
accidents. Despite these differences in predisposition in our
series, the neurological state at admission, including the
GCS score and Markwalder grade, did not differ between
the two age groups.
Fogelholm et al observed that younger patients had
more evidence of increased intracranial pressure, and
older patients had more evidence of mental deterioration
and pyramidal tract lesions.8 The same presentations were
documented in other studies.9,10 In our investigation,
hemiparesis occurred in 36% of younger CSDH patients and
60% of older patients. Tanaka et al suggest that CSDH may
induce neurological dysfunction primarily through
mechanical distortion of the central brain regions, such as
the thalamus, with the influence on the remote regions
attributable to transneural depression.11 Unlike the aged,
who have a decreasing brain volume, young adults have
less intracranial capacity to allow hematoma expansion and
deep cerebral distortion, without increased intracranial
pressure. Therefore, the observation that young patientsoups of patients with CSDH.
>65 y p
n Z 70
6 12.71  12.92 0.58
9 >0.99
3 0.56
9 0.53
6/64 0.18
14 W.-L. Lo et al.had more neurological deficits and a shorter interval from
trauma to operation is a logical result of the physiological
differences that occur in the brain.8
The CT features of CSDH, and their relation to age, have
not so far been well evaluated in the literature. Our anal-
ysis showed that layering of the hematoma is rare in
younger patients. As stated by Kao, the CT appearance of
a sharp interface demarcating a large, high-density area
from a low-density area, strongly suggests that a recent
major hemorrhage has occurred into a well-developed
hematoma, and smears made from the contents of the
hematoma also show many fresh red cells.12 Hence, this
imaging characteristic indicates that repeated intra-
hematoma hemorrhage is unusual in young patients with
CSDH. Another CT presentation which is different between
the two age groups is the lower incidence multiplicity of
hematoma cavities in the younger group. The pathogenesis
of the development of CSDH, is that blood in the subdural
space evokes an inflammatory reaction, resulting in depo-
sition of fibrin, which is followed by the organization and
formation of subdural neomembranes with ingrowth of
neocapillaries.13 Subsequently, both the breaking down of
fibrin and fibrinogen, and the production of an extraordi-
narily large amount of fibrinogen degeneration products,
result in the liquefaction of blood clots.14 Repeated
bleeding into the hematoma cavity may induce new
inflammatory processes, with accompanying neo-
membranes or formation of septa, which is responsible for
compartmentalization of the hematoma cavity. As with the
layering of the hematoma, younger adults have a lower
frequency of rebleeding and a shorter interval to diagnosis;
multiplicity of hematoma cavities is not common in this age
group.
We addressed the outcomes of CSDH patients undergoing
burr hole craniotomy with regard to several aspects. The
incidence of recurrence of CSDH is not significantly
different between the two age groups in this study. This
concurs with the report of Lee et al, who found that age is
not a factor affecting CSDH recurrence.15 The use of GOS to
evaluate outcomes revealed that an unfavorable outcome
was found in none of the 28 younger patients, but was
identified in 6/70 older CSDH patients (9%). All of the
younger adults survived during the follow-up period, with
three mortalities in the older population. However, there
was no statistical intergroup difference in the mortality
rate and GOS score. One of the major limitations in our
investigation is that it is a retrospective study with a rela-
tively small sample size, and another is that it lacks data on
long-term outcome. We are therefore not in a position to
draw definite conclusions regarding the influence of age on
the outcomes; further well-designed large series are
needed for this purpose.
In conclusion, presentation of CSDH with hemiparesis is
less common in patients 65 years old. Layering of hema-
toma and multiplicity of hematoma cavities are rarely seenon CT scans in the case of younger adults, which may be
related to a lower frequency of repeated hemorrhage.
Because the clinical presentations and CT features are
different between younger and older age groups, clinicians
should pay keen attention to this variability to facilitate
proper management.
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